Jun 3, 2016

Shire and Baxalta Complete Merger

Shire today completed its previously announced combination with Baxalta forming the leading global company in rare diseases therapies including for primary immunodeficiencies. IPOPI looks forward to continuing with Shire the long-standing collaboration it has had over the years with Baxalta and previously Baxter. For more information please see Shire's official press release here.

World PI Week
IPOPI would be grateful for any support to the important work for primary immunodeficiencies.

Read all

Executive Director: Johan Prevot
Email: johan@ipopi.org
Tel/Fax: +351 21 407 5720
UK office
Firside Main Road Downderry
Cornwall PL11 3LE
United Kingdom

Tel: +44 1503 250 668
Fax: +44 1503 250 961
E-mail: info@ipopi.org
IPOPI is a charity registered in the UK.
Registration No. 1058005